Printer FriendlyThe Institutional Biosafety Committee (IBC) is a university-wide review body that oversees activities involving potentially hazardous biological agents. The IBC ensures that research activities using these materials and conducted at UML are in compliance with the NIH Guidelines, Federal, State and Local laws and regulations. UML is committed to ensuring the safe handling, storage, and disposal of potentially harmful biohazardous materials for research or instructional projects.
IBCs are established specifically for the review of rDNA research but often review other research that includes biohazardous risks to the environment or public health. The broader purview of the committee is at the discretion of the Institution. Compliance reporting (adverse events reporting) is also a responsibility of the IBC. The IBC must, at times, communicate and coordinate review and approval of research projects with the Institutional Animal Care and Use Committee (IACUC) and the Institutional Review Board (IRB). The IBC may also provide recommendations for education and training related to biosafety for all UML faculty, staff and students that may be involved in the use of such materials.